Benzinga - Gainers
- Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.
- BridgeBio Pharma, Inc. (NASDAQ: BBIO) shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia.
- Avalon GloboCare Corp. (NASDAQ: ALBT) shares gained 53.5% to $3.3330.
- Azul S.A. (NYSE: AZUL) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property.
- Kala Pharmaceuticals, Inc. (NASDAQ: KALA) rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmaceuticals with a Buy and raised the price target from $12 to $20.Kala Pharmaceuticals recently said Q4 adjusted EPS results were higher year over year.
- TCR2 Therapeutics Inc. (NASDAQ: TCRR) gained 28% to $1.55 after the company and Adaptimmune announced a strategic combination to create a preeminent cell therapy company for solid tumors.
- Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) surged 25% to $2.28. Bellerophon Therapeutics announced a $5 million registered direct offering with institutional investor.
- Genius Group Limited (NYSE: GNS) gained 22.5% to $4.4493.
- Entera Bio Ltd. (NASDAQ: ENTX) rose 22.1% to $1.2206 after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) gained 21.8% to $2.51 amid strong Brazilian air travel numbers.
- Orchard Therapeutics plc (NASDAQ: ORTX) jumped 21.3% to $0.57 after the company posted a narrower quarterly loss.
- Borqs Technologies, Inc. (NASDAQ: BRQS) gained 17.2% to $0.2810. Borqs sees preliminary FY22 revenue of $53 million to $58 million.
- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) jumped 17% to $0.9920.
- Motorsport Games Inc. (NASDAQ: MSGM) jumped 16% to $11.16. Motorsport Games recently announced a $4.03 million registered direct offering.
- Armata Pharmaceuticals, Inc. (NYSE: ARMP) gained 15.8% to $3.20 after the company announced topline data from the Phase 1b/2a SWARM-P.a. clinical trial of inhaled AP-PA02 in patients with cystic fibrosis.
- Troika Media Group, Inc. (NASDAQ: TRKA) rose 15.6% to $0.5968 after dropping over 4% on Friday.
- Snap Inc. (NYSE: SNAP) gained 11.3% to $11.85.
- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) rose 9.4% to $2.7251 after declining around 3% on Friday.
- Secoo Holding Limited (NASDAQ: SECO) rose 7.5% to $1.0750 after dipping over 31% on Friday.
- Hertz Global Holdings, Inc. (NYSE: HTZ) shares rose 7.4% to $20.18. Hertz Global will replace Pebblebrook Hotel Trust in the S&P MidCap 400 effective Monday, March 20.
- BuzzFeed, Inc. (NASDAQ: BZFD) rose 6.7% to $1.6540. BuzzFeed is expected to release its Q4 financial results on Monday, March 13, 2023, after the closing bell.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares dipped 54.5% to $5.82 after the company announced its Phase 2A study of Zunsemetinib for Hidradentis Suppurativa did not meet its primary or secondary endpoints.
- Embark Technology, Inc. (NASDAQ: EMBK) dropped 32.4% to $2.56. On March 1, 2023, Embark Technology board approved a reduction in its current workforce by approximately 230 employees.
- Recon Technology, Ltd. (NASDAQ: RCON) fell 27.7% to $1.3073.
- Rubius Therapeutics, Inc. (NASDAQ: RUBY) fell 22.3% to $0.0970 after gaining 10% on Friday.
- Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 22% to $4.9450 after the company published new data on its treatment to reduce cardiovascular risk.
- Yoshiharu Global Co. (NASDAQ: YOSH) dropped 21.5% to $1.7190.
- Digital Media Solutions, Inc. (NYSE: DMS) dropped 19.3% to $0.9123. Digital Media Solutions, Inc. signed an agreement to acquire the HomeQuote.io home services marketplace from Customer Direct Group along with their brand direct international ad network.
- Science 37 Holdings, Inc. (NASDAQ: SNCE) fell 17.7% to $0.2630 after the company posted a Q4 loss and files for mixed shelf of up to $100 million.
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) dropped 17.3% to $1.4550 after the company announced a strategic combination with TCR2 Therapeutics. The company also reported Q4 financial results.
- CECO Environmental Corp. (NASDAQ: CECO) dipped 13.3% to $13.50 after the company posted Q4 results.
- Sidus Space, Inc. (NASDAQ: SIDU) fell 13.1% to $0.76.
- Performance Shipping Inc. (NASDAQ: PSHG) shares fell 12.5% to $0.9703. Performance Shipping recently reported pricing of $12.5 million registered direct offering.
- Addex Therapeutics Ltd (NASDAQ: ADXN) dropped 12.1% to $1.6087.
- ObsEva SA (NASDAQ: OBSV) fell 9.7% to $0.2074. ObsEva shares jumped 117% on Friday following the purchase of 4 million shares by a company director.
- Unisys Corporation (NYSE: UIS) fell 9.1% to $4.4350.
- Oculis Holding AG (NASDAQ: OCS) dropped 8.3% to $9.98.
- IAA, Inc. (NYSE: IAA) fell 7.6% to $38.06.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares fell 7.5% to $0.3998 after gaining 11% on Friday. Vivos Therapeutics recently acquired product rights and patents from Advanced Facialdontics, LLC.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.